A novel mimovirus vaccine containing survivin epitope with adjuvant IL-15 induces long-lasting cellular immunity and high antitumor efficiency.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Molecular Immunology

• Publication date

  2008-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.MOLIMM.2007.10.026PMID 18035418
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Immunological Memory

  2006cited by this paper
• The cationic cell-penetrating peptide CPP(TAT) derived from the HIV-1 protein TAT is rapidly transported into living fibroblasts: optical, biophysical, and metabolic evidence.

  2005cited by this paper
• Cell-penetrating peptide conjugates of peptide nucleic acids (PNA) as inhibitors of HIV-1 Tat-dependent trans-activation in cells

  2005cited by this paper
• Optical calcium sensors: development of a generic method for their introduction to the cell using conjugated cell penetrating peptides.

  2005cited by this paper
• IL-15/IL-15Ralpha-mediated avidity maturation of memory CD8+ T cells.

  2004cited by this paper
• Dendritic cells: a journey from laboratory to clinic

  2004cited by this paper
• IL-15/IL-15Rα-mediated avidity maturation of memory CD8 + T cells

  2004cited by this paper
• Cancer immunotherapy: moving beyond current vaccines

  2004cited by this paper
• Induction of antitumour immunity using survivin peptide‐pulsed dendritic cells in a murine lymphoma model

  2003cited by this paper
• Cell transfection in vitro and in vivo with nontoxic TAT peptide-liposome–DNA complexes

  2003cited by this paper
• Enhancement of antitumor immunity by prolonging antigen presentation on dendritic cells

  2002cited by this paper
• Mimovirus: a Novel Form of Vaccine That Induces Hepatitis B Virus-Specific Cytotoxic T-Lymphocyte Responses In Vivo

  2002cited by this paper
• Vaccines: Effector and memory T-cell differentiation: implications for vaccine development

  2002cited by this paper
• Interleukin 15 Is Required for Proliferative Renewal of Virus-specific Memory CD8 T Cells

  2002cited by this paper
• Translocation of liposomes into cancer cells by cell-penetrating peptides penetratin and tat: a kinetic and efficacy study.

  2002cited by this paper
• Migration of naive, effector and memory T cells: implications for the regulation of immune responses

  2001cited by this paper
• Cell-penetrating peptides.

  2000cited by this paper
• On immunological memory.

  2000cited by this paper
• Prognostic significance of survivin expression in diffuse large B-cell lymphomas.

  2000cited by this paper
• Soluble Antigen and CD40 Triggering Are Sufficient to Induce Primary and Memory Cytotoxic T Cells1

  2000cited by this paper
• Control of homeostasis of CD8+ memory T cells by opposing cytokines.

  2000cited by this paper
• Induction and visualization of mucosal memory CD8 T cells following systemic virus infection.

  1999cited by this paper
• Selecting and maintaining a diverse T-cell repertoire

  1999cited by this paper
• Marked induction of the IAP family antiapoptotic proteins survivin and XIAP by VEGF in vascular endothelial cells.

  1999cited by this paper
• A novel anti-apoptosis gene: Re-expression of survivin messenger RNA as a prognosis marker in non-small-cell lung cancers.

  1999cited by this paper
• Towards development of T-cell vaccines.

  1998cited by this paper
• IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs.

  1998cited by this paper
• Modulation of amplitude and direction of in vivo immune responses by co‐administration of cytokine gene expression cassettes with DNA immunogens

  1998cited by this paper
• Potent and selective stimulation of memory-phenotype CD8+ T cells in vivo by IL-15.

  1998cited by this paper
• Induction of Apoptosis and Inhibition of Cell Proliferation bysurvivin Gene Targeting*

  1998cited by this paper
• Tumor antigens recognized by T lymphocytes

  1997cited by this paper
• Tat-mediated delivery of heterologous proteins into cells.

  1994cited by this paper

• Intratumoral Injection of mRNA Encoding Survivin in Combination with STAT3 Inhibitor Stattic Enhances Antitumor Effects.

  2024cites this paper
• Cell penetrating peptide: A potent delivery system in vaccine development

  2022cites this paper
• VSIG4 Attenuates NLRP3 and Ameliorates Neuroinflammation via JAK2-STAT3-A20 Pathway after Intracerebral Hemorrhage in Mice

  2022cites this paper
• Cell-Penetrating Peptides-Based Liposomal Delivery System Enhanced Immunogenicity of Peptide-Based Vaccine against Group A Streptococcus

  2021cites this paper
• Cell-Penetrating Peptides: Efficient Vectors for Vaccine Delivery

  2019cites this paper
• Mechanistic insights into the efficacy of cell penetrating peptide-based cancer vaccines

  2018cites this paper
• Immunogenicity of a Tripartite Cell Penetrating Peptide Containing a MUC1 Variable Number of Tandem Repeat (VNTR) and A T Helper Epitope

  2018cites this paper
• High Therapeutic Efficacy of a New Survivin LSP-Cancer Vaccine Containing CD4+ and CD8+ T-Cell Epitopes

  2018cites this paper
• Combination immunotherapy with Survivin and luteinizing hormone-releasing hormone fusion protein in murine breast cancer model

  2018cites this paper
• Intron-specific shRNA-mediated downregulation of survivin and promotion of apoptosis in HeLa cells

  2017cites this paper
• Core–shell nanostructures as a platform for sensing applications

  2017cites this paper
• Vaccine delivery by penetratin: mechanism of antigen presentation by dendritic cells

  2016cites this paper
• Proteomic Profiling of Serum Derived Exosomes from Prostate Cancer Patients

  2016cites this paper
• Strategies for Improving Vaccines to Elicit T Cells to Treat Cancer

  2015cites this paper
• Comparative Immunogenicity of a Cytotoxic T Cell Epitope Delivered by Penetratin and TAT Cell Penetrating Peptides

  2015cites this paper
• Cell-penetrating peptides as delivery enhancers for vaccine.

  2014cites this paper
• Nasal immunization using a mimovirus vaccine based on the Eppin B-cell epitope induced suppressed fertility in mice

  2014cites this paper
• Systemic immunotoxicity reactions induced by adjuvanted vaccines.

  2014cites this paper
• siRNA targeting survivin inhibits the growth and enhances the chemosensitivity of hepatocellular carcinoma cells.

  2013cites this paper
• Interleukin-15 in gene therapy of cancer.

  2012cites this paper
• Survivin in Adrenocortical Tumors – Pathophysiological Implications and Therapeutic Potential

  2012cites this paper
• Selection of Adjuvants for Enhanced Vaccine Potency

  2011cites this paper
• Induction of specific immune response and suppression of fertility by B-cell-epitope-based mimovirus vaccine.

  2011cites this paper
• Selection of Optimal Adjuvants and Product Factors that Affect Vaccine Immunogenicity

  2011cites this paper
• Survivin: A target from brain cancer to neurodegenerative disease

  2010cites this paper
• A membrane penetrating multiple antigen peptide (MAP) incorporating ovalbumin CD8 epitope induces potent immune responses in mice.

  2010cites this paper
• Survivin as an immunotherapeutic target for adult and pediatric malignant brain tumors

  2010cites this paper
• Cell-penetrating peptides: application in vaccine delivery.

  2010cites this paper
• Cell-penetrating peptide TAT-mediated delivery of acidic FGF to retina and protection against ischemia–reperfusion injury in rats

  2010cites this paper
• A Novel Pseudovirus Containing Lewis X Oligosaccharides With pD-L1 Targeting to DCs Induces T Cells Tolerance

  2009cites this paper
• Therapeutic effect of a T helper cell supported CTL response induced by a survivin peptide vaccine against murine cerebral glioma

  2008cites this paper
• The Common γ-Chain Cytokines IL-2, IL-7, IL-15, and IL-21 Induce the Expression of Programmed Death-1 and Its Ligands

  2008cites this paper
• Biologics: Targets and Therapy Dovepress Localization and Upregulation of Survivin in Cancer Health Disparities: a Clinical Perspective

  year unknowncites this paper